Pillstats
Tablet

Chlorzoxazone

Chlorzoxazone

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)2410
US makers2 labelers
Packages6
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.163$0.325$0.488$0.651Oct 2025Mar 2026Jul 2026
$0.354
Latest avg · Jul 22, 2026
-37%
Since Oct 22, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

7211.4K2.2K2.9K2025 Q12025 Q22025 Q32025 Q42026 Q1
2.1K
Rx · 2026 Q1
153K
Units dispensed
-8%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Actavis Pharma, Inc.unknown4SUPPLYING
Aurobindo Pharma Limitedunknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.